Advertisement

Topics

Strategies compared for cancer medication submission lags

14:20 EDT 21 Jun 2017 | Medical Xpress

(HealthDay)—For development of oncology drugs in Japan, the global trial (GT) strategy and early-initiation bridging (BG) strategy are associated with shorter submission lag (SL) than late-initiation BG strategy, according to a study published online June 19 in the Journal of Clinical Pharmacology.

Original Article: Strategies compared for cancer medication submission lags

NEXT ARTICLE

More From BioPortfolio on "Strategies compared for cancer medication submission lags"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...